Bornholm disease secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (corrected my editor hyperlink)
Line 2: Line 2:
{{Bornholm disease}}
{{Bornholm disease}}


{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:AroojNaz|Arooj Naz]]
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:AroojNaz|Arooj Naz, M.B.B.S]]


==Overview==
==Overview==

Revision as of 00:20, 19 March 2022

Bornholm disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bornholm disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bornholm disease secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bornholm disease secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bornholm disease secondary prevention

CDC on Bornholm disease secondary prevention

Bornholm disease secondary prevention in the news

Blogs on Bornholm disease secondary prevention

Directions to Hospitals Treating Bornholm disease

Risk calculators and risk factors for Bornholm disease secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S

Overview

Secondary prevention occurs once the disease has developed and aims to prevent progression and development of further complications. Viral meningitis can be prevented by strict isolation, frequent hand washing and appropriate hand hygiene especially after using the bathroom. The development of orchitis may be prevented by surgical correction of underlying UTI's. Hepatitis is avoidable by the use of vaccines and safe eating habits. Pericarditis can be prevented by the concomitant use of aspirin and colchicine. Respiratory distress can be prevented by controlling various properties, including the tidal volume, PEEP, FiO2, and reducing the risk of aspiration by elevating the head end of bed and maintaining oral hygiene.

Secondary prevention

Prevention of complications includes:

  • Acute viral meningitis: strict isolation, frequent hand washing and appropriate hand hygiene especially after using the bathroom [1]
  • Orchitis: surgical correction of underlying UTI's in eligible patients [2]
  • Tidal volume between 6 and 8 mL/kg of body weight
  • Plateau pressure < 30 cm H2O, PEEP ≥ 5 cm H2O
  • Minimize FiO2 (levels >60% lead are associated with oxygen toxicity)
  • Reduce the risk of aspiration (elevate head end of bed, maintain oral hygiene)


References

  1. "StatPearls". 2022. PMID 32491344 Check |pmid= value (help).
  2. "StatPearls". 2022. PMID 31985958.
  3. "StatPearls". 2022. PMID 32119436 Check |pmid= value (help).
  4. Markel G, Imazio M, Brucato A, Adler Y (2013). "Prevention of recurrent pericarditis with colchicine in 2012". Clin Cardiol. 36 (3): 125–8. doi:10.1002/clc.22098. PMC 6649517 Check |pmc= value (help). PMID 23404655.
  5. Beitler JR, Schoenfeld DA, Thompson BT (2014). "Preventing ARDS: progress, promise, and pitfalls". Chest. 146 (4): 1102–1113. doi:10.1378/chest.14-0555. PMC 4188145. PMID 25288000.

Template:WH Template:WS